TransMedics Group Inc (TMDX)

Exchange
NASDAQ
Symbol
TMDX
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Country
USA

Stock price

At close: February 3, 2025

  • Open
    65.00
  • High
    69.31
  • Low
    64.30
  • Close
    68.76
  • Volume
    1,375,680

Financial ratios

Sep 30, 2024